Benefit-risk analysis of adalimumab vs methotrexate and placebo in the treatment of moderate to severe psoriasis

J Am Acad Dermatol. 2010 Oct 6. [Epub ahead of print]

View abstract

Authors

Reich K,  Signorovitch J, Ramakrishnan K, Yu A, Wu EQ, Gupta S, Bao Y, Mulani P